Cocrystal Pharma, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Cocrystal Pharma, Inc. (COCP), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are COCP insiders buying or selling?
Cocrystal Pharma, Inc. insiders reported 10 open-market buys ($2.3M) and 1 sells ($1.7M) across 11 Form 4 filings — a net buying position of $583.7K.
Source: SEC EDGAR Form 4
Key Statistics (as of Feb 25, 2026)
Insider sentiment
Net buyingNet insider flow of $583.7K in net buying.
Recent COCP insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Phillip Frost MD ET AL | Director, 10% Owner | Purchase | 20.0K | $1.00 | $20.0K |
| Feb 9, 2026 | Phillip Frost MD ET AL | Director, 10% Owner | Purchase | 50.0K | $0.95 | $47.3K |
| Jan 2, 2026 | Phillip Frost MD ET AL | Director, 10% Owner | Purchase | 50.0K | $0.95 | $47.3K |
| Dec 31, 2025 | Phillip Frost MD ET AL | Director, 10% Owner | Purchase | 20.0K | $0.97 | $19.3K |
| Dec 29, 2025 | Phillip Frost MD ET AL | Director, 10% Owner | Purchase | 65.0K | $0.97 | $63.2K |
| Nov 28, 2025 | Phillip Frost MD ET AL | Director, 10% Owner | Purchase | 4.0K | $0.99 | $4.0K |
| Nov 26, 2025 | Phillip Frost MD ET AL | Director, 10% Owner | Purchase | 20.0K | $0.94 | $18.8K |
| Apr 6, 2023 | Phillip Frost MD ET AL | Director, 10% Owner | Purchase | 1.0M | $1.97 | $2.0M |
| Aug 23, 2021 | Richard C Pfenniger JR | Director | Purchase | 40.0K | $1.03 | $41.1K |
| May 6, 2021 | Schinazi Raymond F | 10% Owner | Sale | 575.0K | $2.95 | $1.7M |
| Oct 29, 2019 | Schinazi Raymond F | 10% Owner | Purchase | 16.9K | $1.12 | $19.0K |
Showing the 11 most recent of 11 Form 4 filings for Cocrystal Pharma, Inc..
Most active COCP insiders
- Phillip Frost MD ET AL8 filings
- Schinazi Raymond F2 filings
- Richard C Pfenniger JR1 filing
Ask anything about COCP insider activity
Use Trabud's AI agent to query Cocrystal Pharma, Inc.'s Form 4 history in plain English — "Show me COCP CEO purchases this year" or compare it against any other ticker.
Open the AI agentCOCP insider trading FAQ
Are Cocrystal Pharma, Inc. insiders buying or selling?
Across 11 SEC Form 4 filings, Cocrystal Pharma, Inc. (COCP) insiders reported 10 open-market purchases totaling $2.3M and 1 sales totaling $1.7M. That is a net buying position of $583.7K.
How many insiders trade COCP stock?
3 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Cocrystal Pharma, Inc.. The most recent filing was accepted on Feb 25, 2026.
Where does Trabud get COCP insider trading data?
All COCP insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.